Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.80
+0.04 (0.59%)
At close: Jul 3, 2025, 1:00 PM
6.83
+0.03 (0.44%)
After-hours: Jul 3, 2025, 4:59 PM EDT

Novavax Market Cap

Novavax has a market cap or net worth of $1.10 billion as of July 3, 2025. Its market cap has decreased by -44.17% in one year.

Market Cap
1.10B
Enterprise Value
598.58M
1-Year Change
-44.17%
Ranking
Category
Stock Price
$6.80

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.10B, an increase of 4,185.60%. That is a compound annual growth rate of 15.17%.

History

DateMarket Cap% Change
Jul 3, 20251.10B-14.48%
Dec 31, 20241.29B125.87%
Dec 29, 2023570.20M-29.34%
Dec 30, 2022807.00M-92.54%
Dec 31, 202110.82B52.38%
Dec 31, 20207.10B6,609.55%
Dec 31, 2019105.80M-84.98%
Dec 31, 2018704.40M81.13%
Dec 29, 2017388.90M13.78%
Dec 30, 2016341.80M-84.90%
Dec 31, 20152.26B60.10%
Dec 31, 20141.41B32.47%
Dec 31, 20131.07B281.83%
Dec 31, 2012279.60M92.96%
Dec 30, 2011144.90M-46.33%
Dec 31, 2010270.00M8.56%
Dec 31, 2009248.70M90.28%
Dec 31, 2008130.70M-36.71%
Dec 31, 2007206.50M-18.35%
Dec 29, 2006252.90M33.74%
Dec 30, 2005189.10M46.70%
Dec 31, 2004128.90M-28.82%
Dec 31, 2003181.10M182.53%
Dec 31, 200264.10M-80.46%
Dec 31, 2001328.10M97.53%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 316.33B
UnitedHealth Group 279.90B
Novartis AG 242.35B
Abbott Laboratories 233.90B
AstraZeneca 218.65B
Market Cap Rankings